Kearns-Sayre syndrome -3 case reports and review of clinical feature-

Yonsei Medical Journal

Volumn 45, Issue 4, 2004, Pages 727-735

  Park, Seong Bae ^a   Ma, Kyoung Tak ^a   Kook, Koung Hun ^a   Lee, Sang Yeul ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Atypical retinal pigmentary change; Kearns Sayre syndrome; Ptosis; Ragged red fiber

Indexed keywords

UBIDECARENONE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; DEMENTIA; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EYE MOVEMENT DISORDER; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; HUMAN TISSUE; HYPERALDOSTERONISM; KEARNS SAYRE SYNDROME; MALE; MITOCHONDRION; MUSCLE BIOPSY; PTOSIS; RARE DISEASE; RETINA PIGMENT DEGENERATION; STRABISMUS; VISUAL SYSTEM EXAMINATION;

EID: 4644307102     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.4.727     Document Type: Article

References (17)

1. Kearns TP, Sayre GP. Retinitis pigmentosa, External ophthalmoplegia, and complete heart block. Arch Ophthalmol 1958;60:280-9.
2. Berenbaum F, Cote D, Pradat P, Rancurel G. Kearns-Sayre syndrome. Neurology 1990;40:193-4.
3. Ishikawa Y, Goto Y, Ishikawa Y, Minami R. Progression in a case of Kearns-Sayre syndrome. J Child Neurol 2000;15:750-5.
4. Ashizawa T, Subramony SH. What is Kearns-Sayre syndrome after all? Arch Neurol 2001;58:1053-4.
5. Simaan EM, Mikati MA, Touma EH, Rotig A. Unusual presentation of Kearns-Sayre syndrome in early childhood. Pediatr Neurol 1999;21:830-2.
6. Gerbitz KD, Obermaier-Kusser B, Zierz S. Mitochondrial myopathies: divergences of genetic deletions, biochemical defects and the clinical syndromes. J Neurol 1990;237:5-10.
7. Zeviani M, Moraes CT, DiMauro S. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1998;51:1525-32.
8. Brockington M, Alsanjari N, Sweeney MG. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: a molecular genetic and pathological study. J Neurol Sci 1995;131:78-87.
9. Moraes CT, DiMauro S, Zeviani M. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9.
10. Gregory K, Donald RJ. Neuro-ophthalmic manifestation of mitochondrial DNA disorders. Neurol Clin 1991;9: 147-61.
11. Beckerman BL, Henkind P. Progressive external ophthalmoplegia and benign retinal pigmentation. Am J Ophthalmol 1976;81:89-92.
12. Herzberg NH, van Schooneveld MJ, Bleeker-Wagemakers EM. Kearns-Sayre syndrome with a phenocopy of choroideremia instead of pigmentary retinopathy. Neurology 1993;43:218-21.
13. Ota Y, Miyake Y, Awaya S, Kumagai T. Early retinal involvement in mitochondrial myopathy with mitochondrial DNA deletion. Retina 1994;14:270-6.
14. Chabrol B, Paquis V. Cerebral infarction associated with Kearns-Sayre syndrome. Neurology 1997;49:308.
15. Tanji K, Vu TH, Schon EA, DiMauro S, Bonilla E. Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 1999;45:377-83.
16. Ogasahara S, Nishikawa Y, Yorifuji S. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986;36:45-53.
17. Choi C, Sunwoo IN, Kim HS, Kim DI. Transient improvement of pyruvate metabolism after coenzyme Q therapy in Kearns-Sayre syndrome: MRS study. Yonsei Med J 2000;41:676-9.